{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:17:17Z","timestamp":1769062637194,"version":"3.49.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejphar.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T18:15:31Z","timestamp":1518113731000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Treatment with escitalopram modulates cardiovascular function in rats"],"prefix":"10.1016","volume":"824","author":[{"given":"Luiz Fernando","family":"Ver\u00edssimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius Lucca","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane Batista","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia Kimie","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus Vinicius","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Barbosa Moraes","family":"Resstel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Morgan Aguiar","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gislaine Garcia","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.02.003_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.CIR.88.1.180","article-title":"Heart rate variability from 24-h electrocardiography and the 2-year risk for sudden death","volume":"88","author":"Algra","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1469-8986.1997.tb02140.x","article-title":"Heart rate variability: origins, methods, and interpretive caveats","volume":"34","author":"Berntson","year":"1997","journal-title":"Psychophysiology"},{"key":"10.1016\/j.ejphar.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2018.02.003_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autneu.2010.06.003","article-title":"Paraventricular nucleus modulates autonomic and neuroendocrine responses to acute restraint stress in rats","volume":"158","author":"Busnardo","year":"2010","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PSY.0000000000000245","article-title":"Cardiac risk markers and response to depression treatment in patients with coronary heart disease","volume":"78","author":"Carney","year":"2016","journal-title":"Psychosom. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.psy.0000162254.61556.d5","article-title":"Depression, the autonomic nervous system, and coronary heart disease","volume":"67","author":"Carney","year":"2005","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0002-9149(89)90871-0","article-title":"Decreased spontaneous heart rate variability in congestive heart failure","volume":"64","author":"Casolo","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/hm.hm_6_16","article-title":"The safety, efficacy, and tolerability of pharmacological treatment of depression in patients with cardiovascular disease: a look at antidepressants and integrative approaches","volume":"1","author":"Chang","year":"2017","journal-title":"Hear. Mind"},{"key":"10.1016\/j.ejphar.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejphar.2011.09.030","article-title":"Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats","volume":"670","author":"Crestani","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1291\/hypres.30.285","article-title":"Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk","volume":"30","author":"Dawood","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2018.02.003_bib12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0022-3565(25)10485-0","article-title":"Baroreflex control of heart rate in rats with heart failure after myocardial infarction: effects of captopril","volume":"263","author":"Deck","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.02.003_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/10253890.2014.930429","article-title":"Role of the autonomic nervous system and baroreflex in stress-evoked cardiovascular responses in rats","volume":"17","author":"Dos Reis","year":"2014","journal-title":"Stress"},{"key":"10.1016\/j.ejphar.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pcad.2013.03.004","article-title":"Posttraumatic stress disorder and cardiovascular disease","volume":"55","author":"Edmondson","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2018.02.003_bib15","first-page":"653","article-title":"Paroxetine is a novel nitric oxide synthase inhibitor","volume":"32","author":"Finkel","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejphar.2018.02.003_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","article-title":"Depression and 18-month prognosis after myocardial infarction","volume":"91","author":"Frasure-Smith","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(79)90466-1","article-title":"Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats","volume":"25","author":"Fuller","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib18","first-page":"8","article-title":"S-citalopram","volume":"24","author":"Gelenberg","year":"2001","journal-title":"Biol. Ther. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pcad.2006.03.002","article-title":"Baroreflex function in hypertension: consequences for antihypertensive therapy","volume":"48","author":"Grassi","year":"2006","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2018.02.003_bib21","first-page":"930","article-title":"Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors","volume":"11","author":"Grimsley","year":"1992","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejphar.2018.02.003_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2005.07.010","article-title":"The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia","volume":"59","author":"Grippo","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00392-016-0992-y","article-title":"Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure","volume":"105","author":"Gronda","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ejhf.138","article-title":"Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study","volume":"16","author":"Gronda","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00004872-199109000-00010","article-title":"Altered pattern of circadian neural control of heart period in mild hypertension","volume":"9","author":"Guzzetti","year":"1991","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.02.003_bib26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/da.20571","article-title":"Chronic and acute stress and the prediction of major depression in women","volume":"26","author":"Hammen","year":"2009","journal-title":"Depression"},{"key":"10.1016\/j.ejphar.2018.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e3182677041","article-title":"Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome","author":"Hanash","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1838(87)90023-3","article-title":"Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats","volume":"21","author":"Head","year":"1987","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2018.02.003_bib29","doi-asserted-by":"crossref","first-page":"H444","DOI":"10.1152\/ajpheart.00763.2012","article-title":"Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure","volume":"304","author":"Henze","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2013\/398485","article-title":"Blood pressure variability: prognostic value and therapeutic implications","volume":"2013","author":"H\u00f6cht","year":"2013","journal-title":"ISRN Hypertens."},{"key":"10.1016\/j.ejphar.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2017.06.021","article-title":"Chronic fluoxetine treatment enhances sympathetic activities associated with abnormality of baroreflex function in conscious normal rats","volume":"811","author":"Hong","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.pnpbp.2009.07.028","article-title":"Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine","volume":"33","author":"Ikenouchi-Sugita","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PSY.0b013e31823a43e0","article-title":"Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice","volume":"74","author":"Isingrini","year":"2012","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib34","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s00213-013-3374-4","article-title":"Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects","volume":"231","author":"Kemp","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.02.003_bib35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.biopsych.2009.12.012","article-title":"Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis","volume":"67","author":"Kemp","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1176\/ajp.156.6.837","article-title":"Causal relationship between stressful life events and the onset of major depression","volume":"156","author":"Kendler","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","article-title":"Decreased heart rate variability and its association with increased mortality after acute myocardial infarction","volume":"59","author":"Kleiger","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0270(84)90030-X","article-title":"Local cobalt injection: a method to discriminate presynaptic axonal from postsynaptic neuronal activity","volume":"11","author":"Kretz","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2018.02.003_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.jcp.0000085416.08426.1d","article-title":"Paroxetine-induced increase in metabolic end products of nitric oxide","volume":"23","author":"Lara","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib40","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM199411173312008","article-title":"Fluoxetine","volume":"331","author":"Lars","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1476-5381.1990.tb12987.x","article-title":"The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo","volume":"99","author":"Lewis","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/14737175.2014.908709","article-title":"Cardiovascular adverse effects of newer antidepressants","volume":"14","author":"Mago","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2018.02.003_bib43","first-page":"2014","article-title":"Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression","volume":"00337","author":"Matchkov","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.02.003_bib45","doi-asserted-by":"crossref","first-page":"R584","DOI":"10.1152\/ajpregu.00223.2002","article-title":"Short-term fluoxetine treatment enhances baroreflex control of sympathetic nervous system activity after hindlimb unloading","volume":"286","author":"Moffitt","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0028-3908(03)00138-2","article-title":"The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats","volume":"45","author":"M\u00f8rk","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.02.003_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neubiorev.2016.07.018","article-title":"Developmental origins of cardiovascular disease: impact of early life stress in humans and rodents","volume":"74","author":"Murphy","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2018.02.003_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neubiorev.2008.05.026","article-title":"Central 5-HT receptors in cardiovascular control during stress","volume":"33","author":"Nalivaiko","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2018.02.003_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1050-1738(01)00135-9","article-title":"A novel role for serotonin in heart","volume":"11","author":"Nebigil","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5381.2012.01850.x","article-title":"Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice","volume":"168","author":"Nguyen","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9149(91)90774-F","article-title":"Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction","volume":"68","author":"Odemuyiwa","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib52","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.81.3.939","article-title":"Early alterations of the baroreceptor control of heart rate in patients with acute myocardial infarction","volume":"81","author":"Osculati","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.02.003_bib53","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2018.02.003_bib54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1139\/y01-030","article-title":"Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle","volume":"79","author":"Pacher","year":"2001","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.bjp.0702571","article-title":"Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity","volume":"127","author":"Pacher","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/sj.bjp.0702571","article-title":"Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity","volume":"127","author":"Pacher","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1461145799001406","article-title":"Differential effects of fluoxetine and citalopram treatments on serotonin 5-HT(2C) receptor occupancy in rat brain","volume":"2","author":"P\u00e4lvim\u00e4ki","year":"1999","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib58","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1111\/j.1460-9568.2005.04511.x","article-title":"Cardiovascular effects of noradrenaline microinjected into the dorsal periaqueductal gray area of unanaesthetized rats","volume":"22","author":"Pelosi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.autneu.2006.07.002","article-title":"Dorsal periaqueductal gray area synapses modulate baroreflex in unanesthetized rats","volume":"131","author":"Pelosi","year":"2007","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neubiorev.2016.07.003","article-title":"Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms","volume":"74","author":"Penninx","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2018.02.003_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(92)90135-V","article-title":"Effects of central serotonin on autonomic control of heart rate in intact and baroreceptor deficient rats","volume":"582","author":"P\u00e9rgola","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2018.02.003_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0361-9230(01)00612-8","article-title":"Central cardiovascular regulation and 5-hydroxytryptamine receptors","volume":"56","author":"Ramage","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2018.02.003_bib63","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.bjp.0702183","article-title":"The central action of the 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on cardiac inotropy and vascular resistance in the anaesthetized cat","volume":"125","author":"Ramage","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib64","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2007.11.020","article-title":"Cardiovascular effects of l-glutamate injected in the medial prefrontal cortex of spontaneously hypertensive rats","volume":"580","author":"Resstel","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autneu.2006.02.022","article-title":"Involvement of the medial prefrontal cortex in central cardiovascular modulation in the rat","volume":"126\u2013127","author":"Resstel","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib66","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/ajh.2008.189","article-title":"Increased circulating vasopressin may account for ethanol-induced hypertension in rats","volume":"21","author":"Resstel","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.02.003_bib67","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.pnpbp.2006.03.028","article-title":"Effects of escitalopram on ethanol withdrawal syndrome in rats","volume":"30","author":"Sa\u011flam","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-002-1364-z","article-title":"Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities","volume":"167","author":"S\u00e1nchez","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.02.003_bib69","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9149(88)91172-1","article-title":"Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis","volume":"61","author":"Saul","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib70","first-page":"8","article-title":"Physiologic mechanisms of heart rate variability","volume":"14","author":"Stauss","year":"2007","journal-title":"Rev. Bras. Hipertens"},{"key":"10.1016\/j.ejphar.2018.02.003_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pcad.2003.09.001","article-title":"Psychosocial factors in the development of coronary artery disease","volume":"46","author":"Strike","year":"2004","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2018.02.003_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10253890802246659","article-title":"The paraventricular nucleus of the hypothalamus is involved in cardiovascular responses to acute restraint stress in rats","volume":"12","author":"Tavares","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.ejphar.2018.02.003_bib73","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.euroneuro.2013.05.011","article-title":"The cardiovascular safety profile of escitalopram","volume":"23","author":"Thase","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2009.09.543","article-title":"The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors","volume":"141","author":"Thayer","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.02.003_bib75","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrn2647","article-title":"Neural regulation of endocrine and autonomic stress responses","volume":"10","author":"Ulrich-Lai","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2018.02.003_bib76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1751-0759-2-12","article-title":"Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review","volume":"2","author":"van Zyl","year":"2008","journal-title":"Biopsychosoc. Med."},{"key":"10.1016\/j.ejphar.2018.02.003_bib77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12888-014-0349-x","article-title":"The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia\/reperfusion in a model of rats with depression","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ejphar.2018.02.003_bib78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2018.02.003_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12888-017-1335-x","article-title":"Optimized animal model to mimic the reality of stress-induced depression in the clinic","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Psychiatry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:52:59Z","timestamp":1751385179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":79,"alternative-id":["S0014299918300773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.003","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with escitalopram modulates cardiovascular function in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}